NCT06376721 2024-04-19Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell LymphomaBeijing Tongren HospitalPhase 1/2 Recruiting43 enrolled
NCT05320380 2023-09-01A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatChildren's Oncology GroupPhase 1/2 Withdrawn